Alejandra de-la-Torre Selected Research

Alejandra de-la-Torre Research Topics

Disease

13	Ocular Toxoplasmosis 10/2023 - 10/2009
11	Uveitis 05/2024 - 01/2018
9	Infections 03/2023 - 02/2014
7	Toxoplasmosis 04/2024 - 10/2009
4	Glaucoma 02/2024 - 06/2019
4	Cicatrix (Scar) 01/2019 - 02/2007
3	Asymptomatic Infections 01/2019 - 02/2012
2	Retinal Vasculitis 05/2024 - 01/2022
2	Anterior Uveitis 04/2024 - 01/2022
2	Ocular Hypertension (Glaucoma, Suspect) 02/2024 - 01/2024
2	Acute Retinal Necrosis Syndrome 01/2024 - 10/2021
2	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 12/2022
2	Multiple Sclerosis 11/2023 - 10/2021
2	Conjunctivitis 08/2023 - 01/2022
2	Scleritis (Episcleritis) 10/2022 - 05/2020
2	Photophobia (Light Sensitivity) 01/2022 - 09/2021
2	Atrophy 04/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2008
2	Eye Infections 01/2019 - 10/2009
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2024
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024
1	Sclerosing Cholangitis 04/2024
1	Jaundice (Icterus) 04/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024
1	Ganglion Cysts (Ganglion) 02/2024
1	Blindness (Hysterical Blindness) 02/2024
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Optic Nerve Diseases (Optic Neuropathy) 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Paresthesia (Dysesthesia) 11/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2023
1	Intermediate Uveitis (Chronic Cyclitis) 11/2023
1	Relapsing Polychondritis 01/2023
1	Retinal Artery Occlusion 10/2022
1	Amaurosis Fugax 10/2022
1	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 07/2022
1	Retinal Diseases 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Macular Edema 10/2021
1	Graves Ophthalmopathy 10/2021
1	Corneal Edema 10/2021
1	Bacterial Infections (Bacterial Infection) 09/2021
1	Pain (Aches) 09/2021
1	Hyperemia 09/2021
1	Hypersensitivity (Allergy) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Neoplasms (Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 02/2024 - 02/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2008
5	CytokinesIBA 01/2024 - 07/2014
5	AntibodiesIBA 10/2023 - 04/2014
4	Peptides (Polypeptides)IBA 06/2020 - 10/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2024 - 05/2020
3	Adalimumab (Humira)FDA Link 11/2023 - 09/2022
3	Immunoglobulin G (IgG)IBA 07/2022 - 10/2009
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2009
2	EnzymesIBA 04/2024 - 06/2015
2	hydroxide ionIBA 02/2024 - 01/2024
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 11/2023
2	GlucocorticoidsIBA 01/2024 - 01/2024
2	SteroidsIBA 12/2022 - 10/2021
2	Moxifloxacin (Avelox)FDA Link 01/2022 - 09/2021
2	Interleukin-10 (Interleukin 10)IBA 11/2020 - 01/2019
1	HLA-B51 AntigenIBA 05/2024
1	HLA-B Antigens (HLA-B)IBA 05/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024
1	Rituximab (Mabthera)FDA Link 04/2024
1	LipidsIBA 02/2024
1	Biosimilar PharmaceuticalsIBA 01/2024
1	Tumor Necrosis Factor InhibitorsIBA 01/2024
1	Vitamin D FDA LinkGeneric 12/2023
1	Antirheumatic Agents (DMARD)IBA 11/2023
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2023
1	Purinergic P2X7 ReceptorsIBA 10/2023
1	tecovirimatIBA 08/2023
1	Clindamycin (Cleocin)FDA LinkGeneric 03/2023
1	Proteoglycans (Proteoglycan)IBA 01/2023
1	Prothrombin (Factor II)IBA 10/2022
1	Methotrexate (Mexate)FDA LinkGeneric 09/2022
1	Immunoglobulin A (IgA)IBA 07/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Anti-Citrullinated Protein AntibodiesIBA 01/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 10/2021
1	Alemtuzumab (Campath)FDA Link 10/2021
1	Amantadine (Aman)FDA LinkGeneric 10/2021
1	InterferonsIBA 10/2021
1	siponimodIBA 10/2021
1	FluoroquinolonesIBA 09/2021
1	Mydriatics (Cycloplegics)IBA 09/2021
1	Drinking WaterIBA 04/2021
1	Immunoglobulin E (IgE)IBA 01/2021

Therapy/Procedure

11	Therapeutics 05/2024 - 01/2008
2	Immunomodulation 12/2023 - 09/2022
2	Vitrectomy 03/2023 - 01/2008
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2024
1	Intravitreal Injections 01/2024
1	Ventriculoperitoneal Shunt 01/2022
1	Tattooing 01/2021